How Biotech Stock Trevena Could Almost Triple In Value By 2022

By: via Benzinga
In a report published Monday, Brean Capital analyst Jonathan Aschoff initiated coverage of Trevena Inc (NASDAQ: TRVN) with a Buy rating ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.